Sort
51,593 grants matching “hepatitis”
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
$657,911Michael H Nathanson · Yale University · R01 · FY2021 · AA
Role of the Omentum in the Treatment of Morbid Obesity
$657,706Naji N Abumrad · Vanderbilt University · R01 · FY2008 · DK
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
$657,664Monika Sarkar · University Of California, San Francisco · R01 · FY2024 · DK
Liver Disease and HIV-HBV Coinfection in the HAART era
$657,655Chloe L Thio · Johns Hopkins University · R01 · FY2007 · AI
Discovery of SARS-CoV-2 antivirals using a replicon assay
$657,615Stefan G Sarafianos · Emory University · R01 · FY2022 · AI
Apolipoprotein M: a novel regulator of myocardial Autophagy
$657,555Ali Javaheri · Washington University · R01 · FY2021 · HL
Repurposing and reformulation of adefovir dipivoxil for improved topical treatment of herpes simplex virus infection of the eye
$657,537Abhijit A Date · University Of Arizona · R01 · FY2024 · EY
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
$657,468Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2016 · CA
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
$657,403Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection
$657,358Norah A. Terrault · University Of California, San Francisco · U01 · FY2010 · DK
Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning
$657,302Janice E. Chambers · Mississippi State University · U01 · FY2024 · NS
Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis
$657,289M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL
Deep Mutational Scanning of Monogenic Diabetes Genes to Facilitate Precision Diagnostics for Diabetes
$657,261Anna Louise Gloyn · Stanford University · R01 · FY2025 · DK
Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)
$657,227Manal M Hassan · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$657,112Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2009 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$657,066James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mapping Disease Pathways for Biliary Atresia
$657,036Rakesh K. Sindhi · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · DK
Systems Biology Analysis of the Response to 2 HBV vaccines: Heplisav and Engerix
$656,879Robert L Coffman · Baylor Research Institute · U19 · FY2012 · AI
Lead optimization of Hepatitis B Virus ribonuclease H inhibitors
$656,876John E Tavis · Saint Louis University · R01 · FY2022 · AI
Therapeutic HBV vaccines with glucosidase inhibitors
$656,839Thomas Jefferson University · U01 · FY2003 · AI
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
$656,771Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Impact and Utilization of Scalable Functional Assays in Alagille Syndrome
$656,679Melissa Ann Gilbert · Children'S Hosp Of Philadelphia · R01 · FY2024 · DK
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$656,636Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2019 · AI
Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry
$656,602Corinna Nicole Ross · Texas Biomedical Research Institute · R24 · FY2019 · OD
Molecular Mechanisms by which Statins Prevent and Reverse Hepatocellular Carcinoma
$656,499Dean W Felsher · Stanford University · U01 · FY2025 · CA